UPDATES ON MUSCULOSKELETAL ISSUES AND REHABILITATION INTERVENTIONS IN CHRONIC GRAFT-VERSUS-HOST DISEASE

UPDATES ON MUSCULOSKELETAL ISSUES AND REHABILITATION INTERVENTIONS IN CHRONIC GRAFT-VERSUS-HOST DISEASE

Introduction Chronic Graft versus Host Disease (cGvHD) is a long term immunological multi-organ syndrome that may occur after Allogenic Hemopoietic Stem Cell Transplantation (Allo-HSCT). Musculoskeletal issues have been considered a rare complication in cGvHD but recently these issues have been bet...

Full description

Bibliographic Details
Main Authors:	Monica Pinto, Maura Trace, Andrea Cirocco, Paola Trofa, Anna Gentile, Benedetto Di Maio
Format:	Article
Language:	English
Published:	Edisciences 2023-07-01
Series:	Journal of Cancer Rehabilitation
Subjects:	allogenic hemopoietic stem cell transplantion chronic graft versus host disease musculoskeletal issues rehabilitation
Online Access:	https://www.edisciences.org/scheda-j0100-vol-6-issue-3

Similar Items

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Musculoskeletal Chronic Graft versus Host Disease—A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature
by: Alexander Dåtland Kvinge, et al.
Published: (2022-11-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Research progress of endothelial injury in the development of graft-versus-host disease
by: LU Wenqi, WAN Lin
Published: (2023-11-01)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
by: Delaney Wolfe, et al.
Published: (2021-11-01)

Large-vessel vasculitis in graft-versus-host disease: a case report
by: Anmar Al-Heilfi, et al.
Published: (2021-09-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia
by: Tariq Aldebasi, et al.
Published: (2022-07-01)

A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients
by: Mauricio Sarmiento, et al.
Published: (2021-07-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in the Prophylaxis of Graft-Versus-Host Disease: A Systematic Review
by: Jarosław Dybko, et al.
Published: (2023-08-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model
by: Ji-Young Lim, et al.
Published: (2020-06-01)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
by: Sena Kim, et al.
Published: (2020-06-01)

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
by: Maria Iacobescu, et al.
Published: (2024-02-01)

Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease
by: Kristy E. Gilman, et al.
Published: (2023-01-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Low cyclosporine concentrations in children and time to acute graft versus host disease
by: Eun Kyung Chung, et al.
Published: (2020-05-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Correlation of T-Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease
by: Monica Magdalena Rivera Franco, et al.
Published: (2019-10-01)

Vitiligo: an uncommon cutaneous manifestation of graft versus host disease
by: Preema Sinha, et al.
Published: (2022-01-01)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
by: Mehrdad Hefazi, et al.
Published: (2021-09-01)

MicroRNAs: the missing link in the biology of graft-versus-host disease?
by: Sadaf eAtarod, et al.
Published: (2013-12-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-09-01)

PHARMACOECONOMIC ANALYSIS OF DIFFERENT METHODS FOR THE TREATMENT OF STEROID-REFRACTORY GRAFT-VERUS-HOST DISEASE: SINGLE-CENTER STUDY
by: I. S. Moiseev, et al.
Published: (2018-03-01)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
by: Wei C, et al.
Published: (2021-11-01)

Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation
by: J.E.L. Visentainer, et al.
Published: (2002-05-01)

Current status of research and treatment of dry eye associated with chronic ocular graft-versus-host disease
by: Yuan Liang, et al.
Published: (2022-12-01)

Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease
by: Maud D’Aveni, et al.
Published: (2021-02-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review
by: Cristina Hidalgo Calleja, et al.
Published: (2022-08-01)

Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
by: L. A. Kuzmina, et al.
Published: (2020-09-01)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
by: Elizabeth Stenger, et al.
Published: (2022-09-01)

Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
by: HE Yundi, et al.
Published: (2021-11-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families
by: S. Yado, et al.
Published: (2019-11-01)